Kyowa Hakko Kirin Pharma

• A Study to Evaluate Abuse Potential of Istradefylline

  Collaborator, Phase 1, Completed, 42 people, Nov 20, 2015

• Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

  Collaborator, Phase 1, Terminated, 22 people, Jan 19, 2011

• Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

  Collaborator, Phase 1, Terminated, 11 people, Sep 10, 2010

• A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

  Collaborator, Phase 1/2, Completed, 95 people, Feb 5, 2010

Sources: clinicaltrials.gov